Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSealand Cap Regulatory News (SCGL)

Share Price Information for Sealand Cap (SCGL)

Share Price is delayed by 15 minutes
Get Live Data
0.225    -0.025 (-10.00%)
Bid:
0.20
Ask:
0.25
Spread: 0.05 (25.00%)
Market Cap: £14.73m
SCGL Live PriceLast checked at - London Stock Exchange

Intraday Sealand Cap Share Chart

Publication of a Prospectus

7 Nov 2025 12:05

RNS Number : 7144G
Sealand Capital Galaxy Limited
07 November 2025
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED, WHICH BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 FORMS PART OF UK LAW. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

Sealand Capital Galaxy Limited ("Sealand" or the "Company")

 

Publication of a Prospectus

 

Sealand Capital Galaxy Limited [LSE: SCGL], an IT, Social Media and Technology company focused on consolidating compelling opportunities in the global marketplace, announces that the Financial Conduct Authority has approved a prospectus dated 7 November 2025 (the "Prospectus").

 

The Prospectus relates to the admission of 113,628,767 ordinary shares of £0.0001 each to the Equity Shares (Transition) category of the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's main market for listed securities. Admission of the relevant securities is expected to occur at 8:00am on 12 November 2025 ("Admission"). Dealings are expected to commence at the same time.

 

The full Prospectus is available on the Company's website at www.sealandcapitalgalaxy.com and will be submitted to the Financial Conduct Authority's National Storage Mechanism, where it will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Following Admission, the Company's issued share capital will comprise 1,011,534,756 ordinary shares of £0.0001 each, each carrying one vote. The Company does not hold any shares in treasury. The total voting rights figure of 1,011,534,756 may be used by shareholders for the purposes of the FCA's Disclosure Guidance and Transparency Rules.

 

The Board believes the publication of the Prospectus and Admission will provide improved access to capital to support the Company's growth plans as it continues to progress its strategic objectives.

 

-Ends-

 

Enquiries:

 

Sealand Capital Galaxy Limited

Dr. Thomas Sawyer (Chief Executive Officer)

Ms. Elena Law (Chairwoman)

Mr. Geoffrey Griggs (Non-Executive Director)

 

Bowsprit Partners Limited (Financial Adviser)  +44 (0) 203 833 4430

 

Stockbox Media (PR/IR)

info@stockboxmedia.com

 

Noted to the Editors:

 

The Company's Shares are traded on the transition category of the London Stock Exchange under ticker LSE: SCGL.

 

Further information on Sealand Capital Galaxy limited is available on:

 

www.sealandcapitalgalaxy.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIPKOBKBBDDBDK
Date   Source Headline
15th Jun 20267:00 amRNSFinal Results and Notice of AGM
30th Apr 20267:00 amRNSAssignment of CLN Investment in EVOO AI plc
29th Apr 20267:48 amRNSTemporary Suspension
30th Mar 202611:50 amRNSDirector/PDMR Shareholding
30th Mar 202611:38 amRNSCLN Conversion, Exercise of Warrants & TVR
26th Mar 202611:48 amRNSResult of General Meeting
16th Mar 20269:19 amRNSDirector/PDMR Shareholding
16th Mar 20269:19 amRNSDirector/PDMR Shareholding
11th Mar 202611:10 amRNSIssue of Equity
6th Mar 20264:54 pmRNSNotice of General Meeting
17th Feb 20267:00 amRNSAppointment of Financial Adviser
27th Jan 20264:00 pmRNSStrategic Update and Business Expansion
21st Jan 20264:00 pmRNSDirector Appointment and CFO Appointment
6th Jan 202612:43 pmRNSStatement re Share Price Movement
8th Dec 20253:00 pmRNSDirector Appointment
7th Nov 202512:05 pmRNSPublication of a Prospectus
30th Sep 20251:30 pmRNSHalf-year Report
22nd May 202510:22 amRNSExercise of Warrants
30th Apr 20255:00 pmRNSResults of General Meetings of Warrant Holders
30th Apr 20254:55 pmRNSFinal Results for the Year Ended 31 December 2024
25th Apr 20254:11 pmRNSNotice of General Meetings of Warrant Holders
14th Mar 20257:00 amRNS-REVOO AI PLC Appoints Gordon Radley as New Director
6th Mar 20257:00 amRNS-REVOO’s acceptance into the NVIDIA Connect Program
28th Feb 20254:33 pmRNS-RCEO Interviewed by StockBox Media
28th Feb 20257:00 amRNSTotal Voting Rights
26th Feb 20257:00 amRNSSelection of Strategic Development Partner
24th Feb 20257:00 amRNS-RCorporate Update - Strategic Growth Initiatives
31st Jan 20254:32 pmRNSExercise of Convertible Loan Note and TVR
27th Jan 20257:00 amRNSFormation of ‘SEA-VOO AI ASIA’
20th Jan 20259:17 amRNSAppointment of Chief Executive Officer
10th Jan 20252:50 pmRNSAGM RESULTS AND INVESTMENT IN EVOO AI PLC
6th Jan 20253:24 pmRNSStatement re Share Price Movement
30th Dec 20247:00 amRNSConditional Issue of Equity and Issue of CLN
16th Dec 20247:00 amRNSNotice of AGM
4th Dec 20242:07 pmRNSShare Price Movement
22nd Nov 202410:08 amRNSConditional Investment Agreement
30th Sep 20247:00 amRNSInterim Results
11th Sep 20247:00 amRNSIssue of Equity
30th Apr 202412:30 pmRNSFinal Results
29th Jan 20247:00 amRNSIssue of Equity
29th Sep 20237:00 amRNSUnaudited Interim Results
16th Jun 20237:00 amRNSLifting of suspension, recommencement of trading
6th Jun 202310:11 amRNSREPLACEMENT: MOU WITH PARTNER IN GREATER CHINA
6th Jun 20239:13 amRNSMOU SIGNED WITH PARTNER IN GREATER CHINA
5th Jun 20233:02 pmRNSFinal results for the year ended 31 December 2022
2nd May 20237:57 amRNSDELAY IN PUBLISHING AUDITED FINANCIAL STATEMENTS
17th Apr 20237:00 amRNSHH Simonsen distributorship agreement update
30th Dec 20227:00 amRNSTotal Voting Rights
21st Dec 20227:00 amRNSIssue of Equity
27th Sep 20227:00 amRNSUnaudited Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.